Poop pills from skinny donors: a new weapon against obesity?
NCT ID NCT06268990
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed pilot study tested whether transferring gut bacteria from lean donors or from people who had gastric bypass surgery could improve metabolism in 29 obese adults with prediabetes or diabetes. Participants received fecal transplants, and researchers measured changes in insulin sensitivity and blood sugar. The goal was to see if changing gut bacteria could help manage obesity and related conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fecal microbiota transplantation
- What this could lead to
- If it works, this could point toward a new way to treat obesity and related metabolic problems by changing gut bacteria.
- What could go wrong
- This is a small, early pilot study with only 29 people. Results may not apply to everyone, and the effects might be short-lived.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Internal Medicine, Medical University Graz
Graz, 8010, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
- A new rice could tame blood sugar spikes in prediabetes
- Ancient herb huangjing put to the test against hidden belly fat
- Could everyday supplements turn back the clock on aging?
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?